Compumedics Limited (ASX:CMP)
Australia · Delayed Price · Currency is AUD 0.2550
0.00 (0.00%)
Aug 28, 2026, 1:18 PM AEST
Compumedics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 60.25 | 50.83 | 49.72 | 42.41 | 37.76 |
Other Revenue | 1.62 | 0.21 | 0.54 | 0.52 | 0.85 |
| 61.88 | 51.04 | 50.26 | 42.92 | 38.61 | |
Revenue Growth | 21.23% | 1.55% | 17.10% | 11.18% | 8.02% |
Cost of Revenue | 29.28 | 22.91 | 23.65 | 20.82 | 18.44 |
Gross Profit | 32.6 | 28.13 | 26.61 | 22.11 | 20.17 |
Selling, General & Admin | 24.44 | 25.89 | 21.14 | 19.66 | 15.13 |
Research & Development | 4.75 | 1.34 | 5.74 | 5.46 | 4.06 |
Operating Expenses | 29.19 | 27.23 | 26.88 | 25.12 | 19.18 |
Operating Income | 3.41 | 0.9 | -0.27 | -3.02 | 0.99 |
Interest Expense | -1.51 | -1.29 | -0.74 | -0.65 | -0.4 |
Currency Exchange Gain (Loss) | -0.24 | -0.02 | -0.18 | 0.04 | 0.17 |
EBT Excluding Unusual Items | 1.66 | -0.41 | -1.19 | -3.63 | 0.76 |
Asset Writedown | - | - | 1.67 | -3.09 | - |
Other Unusual Items | - | - | - | - | 0.94 |
Pretax Income | 1.66 | -0.41 | 0.48 | -6.72 | 1.7 |
Income Tax Expense | 1.45 | 0.86 | 0.82 | -0.6 | 0.34 |
Net Income | 0.21 | -1.27 | -0.34 | -6.12 | 1.36 |
Net Income to Common | 0.21 | -1.27 | -0.34 | -6.12 | 1.36 |
Net Income Growth | - | - | - | - | 35.97% |
Shares Outstanding (Basic) | 214 | 188 | 177 | 177 | 177 |
Shares Outstanding (Diluted) | 214 | 188 | 177 | 177 | 177 |
Shares Change | 13.67% | 6.26% | - | - | - |
EPS (Basic) | 0.00 | -0.01 | -0.00 | -0.03 | 0.01 |
EPS (Diluted) | 0.00 | -0.01 | -0.00 | -0.03 | 0.01 |
EPS Growth | - | - | - | - | 35.97% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 6.42 | 0.23 | 1.69 | -0.88 | 2.67 |
Free Cash Flow Per Share | 0.03 | 0.00 | 0.01 | -0.01 | 0.01 |
Gross Margin | 52.69% | 55.11% | 52.94% | 51.50% | 52.25% |
Operating Margin | 5.51% | 1.75% | -0.53% | -7.03% | 2.56% |
Profit Margin | 0.35% | -2.48% | -0.67% | -14.26% | 3.52% |
Free Cash Flow Margin | 10.38% | 0.46% | 3.36% | -2.04% | 6.92% |
EBITDA | 4.82 | 1.4 | 0.24 | -2.6 | 1.5 |
EBITDA Margin | 7.78% | 2.74% | 0.47% | -6.05% | 3.89% |
D&A For EBITDA | 1.41 | 0.5 | 0.51 | 0.42 | 0.51 |
EBIT | 3.41 | 0.9 | -0.27 | -3.02 | 0.99 |
EBIT Margin | 5.51% | 1.75% | -0.53% | -7.03% | 2.56% |
Effective Tax Rate | 87.12% | - | 170.42% | - | 20.08% |